The formation of inclusion complexes of Hyptis pectinata essential oil (EOHP), with potent activities such as anti-nociceptive, anti-inflammatory, among others, with β -cyclodextrin (β-CD), was obtained by slurry (SC) and paste procedures (PC). The gas chromatography coupled to the mass spectrometry (GC/MS) analysis demonstrated a total of 36.4% monoterpenes and 63.6% sesquiterpenes in the EOHP. The major components of EOHP were identified as (E)- caryophyllene (54.07%). The analysis of samples (PM, PC and SC) by GC/MS involved the surface and the total extracted oils. The GC/MS results suggested important differences between in SC and PC methods indicating the complexation of mono and sesquiterpenoids in different ratios. Furthermore, the thermal analysis techniques suggests the complexation, especially in SC, which show a thermogravimetry/derivative thermogravimetry (TG/DTG) peak at 140-270ºC, probably related to oil loss. Scanning electron microscopy (SEM) images showed reduction size of the samples mainly in the SC product. Additionally, EOHP/ β-CD improves pharmacological profile of EOHP alone in formalin-induced pain protocol in mice.

The inclusion complex with LGEO was a feasible formulation, being economically viable, easy-to-apply and without impact on non-target organisms and, therefore, is a potential alternative larvicide for Ae. aegypti control. © 2018 Society of Chemical Industry.

No abstract

Lippia grata Schauer (Verbenaceae) leaves essential oil/β‐cyclodextrin (EO/β‐CD) complex was used to evaluated if the complex formulation is able in reduces orofacial behavior in mice. Male Swiss mice were pretreated with EO/β‐CD (50, 100 and 200 mg/kg, p.o., per os, orally), morphine (5 mg/kg, i.p.) or vehicle (distilled water). Ninety minutes after the treatment, we injected formalin (20 μL, 2%), capsaicin (20 μL, 2.5 μg) or glutamate (40μL, 25 μM) into the right upper lip (perinasal area). For the action in the CNS, 90 minutes after the treatment, the animals were perfused, the brains collected, and submitted in an immunofluorescence protocol for Fos protein. Experimental protocols were approved by the Animal Care and Use Committee at the UFS (# 57/11). EO/β‐CD produced significant (p< 0,05; p<0.01) antinociceptive effect, in the formalin‐, capsaicin‐and glutamate‐induced orofacial nociception. The immunofluorescence showed that the EO/β‐CD activated significantly (p<0.05) the olfactory bulb, the piriform cortex, and the periaqueductal grey of the CNS. Together, our results provide first‐time evidence that EO/β‐CD attenuates orofacial nociception at least, in part, through an activation of CNS areas, such as periaqueductal grey.